NCT07165899

Brief Summary

This study aims to explore the potential of binaural beats, adjusted in real-time via EEG feedback, to positively influence brain states related to relaxation, focus, and cognitive performance. The investigators are examining how these auditory techniques can improve memory, attention, and overall subjective well-being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 16, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 26, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 26, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2025

Completed
27 days until next milestone

First Posted

Study publicly available on registry

September 10, 2025

Completed
Last Updated

September 10, 2025

Status Verified

September 1, 2025

Enrollment Period

3 months

First QC Date

August 14, 2025

Last Update Submit

September 2, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Stop Signal Reaction Time

    Estimated time (milliseconds) required to inhibit a prepotent response following a stop signal, derived from the integration method. Lower values indicate better inhibitory control.

    Baseline (At visit 2 or 3, immediately prior to 30-minute intervention/control audio session) and immediately post-intervention/control audio session (within 10 minutes after completion of session).

  • Reaction Time on Novelty Encoding Task

    Mean response latency (seconds) during the novelty encoding task recognition phase. Lower values indicate faster information retrieval and decision speed without implying a speed-accuracy trade-off. The unit of measurement is in seconds.

    Baseline (at visit 2 or 3, immediately prior to 30-minute intervention/control audio session) and immediately post-intervention/control audio session (within 20 minutes after completion of session).

  • Predominant Frequency and Frequency Band from a Single Prefrontal Electrode

    EEG data were segmented into epochs and subjected to quality control procedures. For each epoch, sample entropy was calculated as a measure of signal irregularity. Epochs with entropy values above the 75th percentile were classified as high-noise and excluded from further analysis. The remaining epochs were standardized by z-scoring, transformed to the frequency domain, and then summarized into standard bands (delta: 0.5-4 Hz, theta: 4-8 Hz, low-alpha: 8-10 Hz, high-alpha: 10-12 Hz, low-beta: 12-18 Hz, high-beta: 18-32 Hz) to facilitate comparison across participants and conditions.

    The duration of the audio intervention was 30 minutes. Predominant frequency and frequency bands were measured as baseline, 5, 10, 15, 20, 25 minutes, and at the end of the session (at 30 minutes).

Secondary Outcomes (7)

  • Visual Analogue Scale - Subjective Relaxation

    Baseline (At visit 2 or 3, immediately prior to 30-minute intervention/control audio session) and immediately post-intervention/control audio session (within 20 minutes after completion of session).

  • Visual Analogue Scale - Sleepiness

    Baseline (At visit 2 or 3, immediately prior to 30-minute intervention/control audio session) and immediately post-intervention/control audio session (within 20 minutes after completion of session).

  • Visual Analogue Scale - Focus

    Baseline (At visit 2 or 3, immediately prior to 30-minute intervention/control audio session) and immediately post-intervention/control audio session (within 20 minutes after completion of session).

  • Visual Analogue Scale - Cognitive Performance

    Baseline (At visit 2 or 3, immediately prior to 30-minute intervention/control audio session) and immediately post-intervention/control audio session (within 20 minutes after completion of session).

  • Visual Analogue Scale - Overall Well-Being

    Baseline (At visit 2 or 3, immediately prior to 30-minute intervention/control audio session) and immediately post-intervention/control audio session (within 20 minutes after completion of session).

  • +2 more secondary outcomes

Study Arms (2)

EEG-Guided Binaural Beat Audio

EXPERIMENTAL

30-minute audio session with dynamic frequency adjustments based on real-time EEG feedback

Behavioral: EEG-Guided Binaural Beat Audio

Sham Control

SHAM COMPARATOR

30-minute audio session with identical tones presented to both ears, EEG monitored but not used for frequency adjustment

Behavioral: Sham Control

Interventions

30-minute audio session with dynamic frequency adjustments based on real-time EEG feedback

EEG-Guided Binaural Beat Audio
Sham ControlBEHAVIORAL

30-minute audio session with identical tones presented to both ears (no binaural beat), EEG monitored but not used for frequency adjustment

Sham Control

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female adults (age \> 18 years)

You may not qualify if:

  • Cognitive impairment (self-reported)
  • Gross visual, auditory, or motor impairments; severe physical, psychiatric, or neurological impairments
  • History of epilepsy, seizures, or seizure-like episodes
  • History of intracranial lesions, stroke, traumatic brain injury, neoplasms, cranial surgery, or foreign bodies
  • Current daily alcohol or substance abuse
  • Current daily use of medications affecting EEG activity (e.g., anti-epileptics, opioids) or lowering seizure threshold
  • Self-reported auditory hypersensitivity or prior adverse effects from audio stimulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Tech University Health Sciences Center, Lubbock, TX, USA

Lubbock, Texas, 79430, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Both participants and research staff will be blinded to condition; randomization and condition assignment are automated within the PsychoPy script.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomized, double-blinded, sham-controlled, repeated-measures crossover design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 14, 2025

First Posted

September 10, 2025

Study Start

August 16, 2024

Primary Completion

November 26, 2024

Study Completion

November 26, 2024

Last Updated

September 10, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

De-identified individual participant data may be shared with qualified researchers upon a reasonable request and after obtaining institutional approval.

Locations